Multiple sclerosis lesions: Relationship between MR enhancement pattern and magnetization transfer effect

American Journal of Neuroradiology

Volumn 17, Issue 6, 1996, Pages 1041-1049

  Petrella, Jeffrey R ^a,b   Grossman, Robert I ^a   McGowan, Joseph C ^a   Campbell, Gregory ^b   Cohen, Jeffrey A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Magnetic resonance, contrast enhancement; Magnetic resonance, magnetization transfer; Sclerosis, multiple

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; MYELIN;

ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; CONTRAST MEDIA; DRUG COMBINATIONS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MEGLUMINE; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID;

EID: 0029889099     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Prineas JA, Pathology of early lesion in multiple sclerosis. Hum Pathol 1975;6:531-554
2. Prineas JW, Connel F. The fine structure of chronically active multiple sclerosis plaques. Neurology 1978;28:68-75
3. Stewart WA, Hall LD, Churg A, Oger J, Hashimoto SA, Paty DW. Magnetic resonance imaging (MRI) in multiple sclerosis (MS): pathological correlation studies in eight cases. Neurology 1986;36(suppl 1):109
4. Wolff SD, Balaban RS. Magnetization transfer imaging: practical aspects and clinical applications. Radiology 1994;192:593-599
5. Koenig SH. Cholesterol of myelin is the determinant of gray-white contrast in MR imaging of the brain. Magn Reson Med 1991;20:285-291
6. Dousset V, Grossman RI, Ramer KM, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491
7. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467-474
8. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34:661-669
9. Tomiak MM, Jordan RD, Prager JM, Metz CE. Magnetization transfer: a potential method to determine the age of multiple sclerosis lesions. AJNR Am J Neuroradiol 1994;15:1569-1574
10. Hiehle JF, Grossman RI, Ramer KM, Gonzalez-Scarano F, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison of gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77
11. Poser CM, Paty DW, Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
12. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York, NY: John Wiley & Sons; 1973
13. Grossman RI, Gonzalez-Scarano F, Atlas SW, Galetta S, Silberberg DH. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986;161:721-725
14. McDonald WI. The dynamics of multiple sclerosis. J Neurol 1993;240:28-36
15. McGowan JC, Leigh JS. Selective saturation in magnetization transfer experiments. Magn Reson Med 1994;32:517-522
16. Stone LA, Frank JA, Albert PS, et al. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhance magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 1995;37:611-619